| Title |
Cisplatin Resistance Associated with PARP Hyperactivation
|
|---|---|
| Published in |
Cancer Research, April 2013
|
| DOI | 10.1158/0008-5472.can-12-3000 |
| Pubmed ID | |
| Authors |
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, Julien Adam, Ken André Olaussen, Oliver Kepp, Laura Senovilla, Ibtissam Talhaoui, Justine Guegan, David Pierre Enot, Monique Talbot, Angélique Robin, Philippe Girard, Cédric Oréar, Delphine Lissa, Abdul Qader Sukkurwala, Pauline Garcia, Parviz Behnam-Motlagh, Kimitoshi Kohno, Sheng Wu, Catherine Brenner, Philippe Dessen, Murat Saparbaev, Jean-Charles Soria, Maria Castedo, Guido Kroemer |
| Abstract |
Non-small cell lung carcinoma patients are frequently treated with cisplatin (CDDP), most often yielding temporary clinical responses. Here, we show that PARP1 is highly expressed and constitutively hyperactivated in a majority of human CDDP-resistant cancer cells of distinct histologic origin. Cells manifesting elevated intracellular levels of poly(ADP-ribosyl)ated proteins (PAR(high)) responded to pharmacologic PARP inhibitors as well as to PARP1-targeting siRNAs by initiating a DNA damage response that translated into cell death following the activation of the intrinsic pathway of apoptosis. Moreover, PARP1-overexpressing tumor cells and xenografts displayed elevated levels of PAR, which predicted the response to PARP inhibitors in vitro and in vivo more accurately than PARP1 expression itself. Thus, a majority of CDDP-resistant cancer cells appear to develop a dependency to PARP1, becoming susceptible to PARP inhibitor-induced apoptosis. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 50% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| South Africa | 1 | <1% |
| United States | 1 | <1% |
| Italy | 1 | <1% |
| Czechia | 1 | <1% |
| Unknown | 112 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 26% |
| Student > Ph. D. Student | 24 | 20% |
| Student > Master | 12 | 10% |
| Professor > Associate Professor | 7 | 6% |
| Student > Doctoral Student | 6 | 5% |
| Other | 23 | 19% |
| Unknown | 15 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 28 | 24% |
| Biochemistry, Genetics and Molecular Biology | 27 | 23% |
| Medicine and Dentistry | 25 | 21% |
| Chemistry | 9 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Other | 6 | 5% |
| Unknown | 18 | 15% |